Merck’s Injectable Keytruda Plans Create Authorized Dispute With Halozyme: WSJ
An investigational injectable formulation of Merck’s blockbuster most cancers drug Keytruda is creating authorized complications for the corporate as Halozyme...
Pharmaceutical Updates
FDA approves BeiGene’s Tevimbra for oesophageal most cancers
Tevimbra plus chemotherapy was beforehand authorised to deal with superior gastric and gastroesophageal junction cancers. Credit score: Orawan Pattarawimonchai/Shutterstock. The...
23andMe’s Anne Wojcicki, Illumina, Capricor
Need to keep on high of the science and politics driving biotech in the present day? Enroll to get our biotech e-newsletter...
Atara Halves Workforce Once more, Pauses 2 CAR T Packages
For the second time this yr and following a call to pause two CAR T applications, Atara Biotherapeutics has divulged...
MWC Barcelona 2025: Maximizing 5G community worth within the age of AI
Li Peng, Huawei’s Company Senior Vice President and President of ICT Gross sales & Service, talking at MWC Barcelona 2025....
